# Bi-atrial Versus Left Atrial Ablation for Patients With Rheumatic Mitral Valve Disease and Non-paroxysmal Atrial Fibrillation

> **NCT05021601** · NA · RECRUITING · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 320 (estimated)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **PROCEDURE:** Bi-atrial ablation
- **PROCEDURE:** Left atrial ablation

## Key facts

- **NCT ID:** NCT05021601
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-10
- **Primary completion:** 2025-06
- **Final completion:** 2025-07
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2024-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05021601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05021601, "Bi-atrial Versus Left Atrial Ablation for Patients With Rheumatic Mitral Valve Disease and Non-paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05021601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*